Assoc. Prof. Phạm Văn Thái

Profile 7/10

Hanoi Medical University · Medicine and Pharmacy

19 publications · 25 citations · h-index 3

Information

🏛️Affiliation: Hanoi Medical University
🔬Field: Medicine and Pharmacy
🆔ORCID: 0009-0005-3073-8406
🎂Born: 1978
🏅Qualified as Assoc. Prof 2025
✍️Profile incomplete — add information

Data sources: Source: State Council for Professorship of Vietnam — list of candidates meeting the standards for Professor and Associate Professor, 2025. Compiled from official public sources; the scholar may claim, update or request removal of this profile at any time.

Featured publications

BRCA mutation in Vietnamese prostate cancer patients: a mixed cross-sectional study and case series5 citations
ONCOLOGIE · 2024 · DOI

The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases3 citations
Asia-Pacific Journal of Clinical Oncology · 2024 · DOI

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 citations
Therapeutic Advances in Medical Oncology · 2024 · DOI

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam3 citations
BMC Cancer · 2024 · DOI

Efforts in the Formation and Development of Nuclear Medicine in Vietnam2 citations
Nuclear Medicine and Molecular Imaging · 2019 · DOI

Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study2 citations
Asian Pacific Journal of Cancer Prevention · 2024 · DOI

Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 citations
Therapeutic Advances in Medical Oncology · 2025 · DOI

A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 citations
Research Square · 2023 · DOI

Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI

A case report of sarcomatoid hepatocellular carcinoma treated multimodality
Advances in Radiotherapy & Nuclear Medicine · 2025 · DOI

About the field of Medicine and Pharmacy

6,619researchers 91,896publications 2,589,484citations 4.2average h-index

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field: